Back to Journals » Breast Cancer: Targets and Therapy » Volume 4

Review

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

          
Total article views   Abstract views HTML views PDF downloads Totals
10,663 Dovepress* 8,944 430+ 2,630 9,374
PubMed Central* 1 1,288 1,357 1,289
Totals 8,945 1,718 3,987 10,663
*Since 27 August 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar